Evaluating the Safety, Tolerability, and Pharmacokinetics of an Investigational, Injectable HIV Medicine (GSK1265744) in HIV-Uninfected Adults
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Instituto de Pesquisa Clinica Evandro Chagas (ipec) Crs
Rio de Janeiro, Brazil
- Malawi Crs
Lilongwe, Malawi
- Soweto Hptn Crs
Johannesburg, Gauteng, South Africa
- Vulindlela Crs
Durban, KwaZulu-Natal, South Africa
- Ucla Care Center Crs
Los Angeles, California, United States
- Bridge Hiv Crs
San Francisco, California, United States
- George Washington Univ. Crs
Washington D.C., District of Columbia, United States
- Chapel Hill Crs
Chapel Hill, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2015
- Primary completion
- 5 Apr 2017
- Completion
- 13 Jul 2018
- Last update posted
- 18 Oct 2021
- Registered enrollment
- 199
- Registry id
- NCT02178800
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.